Increase in exhaled nitric oxide and protective role of the nitric oxide system in experimental pulmonary embolism

British Journal of Pharmacology

Volumn 150, Issue 4, 2007, Pages 494-501

  Nilsson, K F ^a   Gustafsson, L E ^a   Adding, L C ^a   Linnarsson, D ^a   Agvald, P ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cardiovascular system; Lung diseases; Nitric oxide; Nitric oxide synthase; Pulmonary embolism; Respiratory system

Indexed keywords

N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL EMBOLISM; BLOOD GAS; CONTROLLED STUDY; DOSE RESPONSE; GAS EMBOLISM; LUNG EMBOLISM; MALE; MUSCLE TISSUE; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; SURVIVAL RATE; SURVIVAL TIME;

ANESTHESIA; ANIMALS; BLOOD GAS ANALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; INFUSIONS, INTRAVENOUS; MUSCLE, SKELETAL; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PULMONARY EMBOLISM; RABBITS; RESPIRATION, ARTIFICIAL; SURVIVAL ANALYSIS;

EID: 33847103765     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0707001     Document Type: Article

References (47)

1. Adding LC, Agvald P, Persson MG, Gustafsson LE (1999). Regulation of pulmonary nitric oxide by carbon dioxide is intrinsic to the lung. Acta Physiol Scand 167: 167-174.
2. Adding LC, Gustafsson LE (2002). Physiology of exhaled nitric oxide. In: Marczin N, Kharitonov S, Yacoub MH, Barnes PJ (eds). Disease Markers in Exhaled Breath. Mercel Dekker Inc: New York, pp 29-72.
3. Agvald P, Adding LC, Artlich A, Persson MG, Gustafsson LE (2002). Mechanisms of nitric oxide generation from nitroglycerin and endogenous sources during hypoxia in vivo. Br J Pharmacol 135: 373-382.
4. 2 and endogenous NO after venous gas embolism in rabbits. Eur J Appl Physiol 97: 210-215.
5. ATS/ERS (2005). ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 171: 912-930.
6. Berg JT, Deem S, Kerr ME, Swenson ER (2000). Hemoglobin and red blood cells alter the response of expired nitric oxide to mechanical forces. Am J Physiol Heart Circ Physiol 279: H2947-H2953.
7. Berkman N, Avital A, Breuer R, Bardach E, Springer C, Godfrey S (2005). Exhaled nitric oxide in the diagnosis of asthma: comparison with bronchial provocation tests. Thorax 60: 383-388.
8. Bottiger BW, Motsch J, Dorsam J, Mieck U, Gries A, Weimann J et al. (1996). Inhaled nitric oxide selectively decreases pulmonary artery pressure and pulmonary vascular resistance following acute massive pulmonary microembolism in piglets. Chest 110: 1041-1047.
9. Cherry PD, Gillis CN (1987). Evidence for the role of endothelium-derived relaxing factor in acetylcholine-induced vasodilatation in the intact lung. J Pharmacol Exp Ther 241: 516-520.
10. Deem S, McKinney S, Polissar NL, Hedges RG, Swenson ER (1999). Hemodilution during venous gas embolization improves gas exchange, without altering V(A)/Q or pulmonary blood flow distributions. Anesthesiology 91: 1861-1872.
11. Di Rosa M, Radomski M, Carnuccio R, Moncada S (1990). Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages. Biochem Biophys Res Commun 172: 1246-1252.
12. Dikshit M, Kumari R, Srimal RC (1993). Pulmonary thromboembolism-induced alterations in nitric oxide release from rat circulating neutrophils. J Pharmacol Exp Ther 265: 1369-1373.
13. Emerson M, Momi S, Paul W, Alberti PF, Page C, Gresele P (1999). Endogenous nitric oxide acts as a natural antithrombotic agent in vivo by inhibiting platelet aggregation in the pulmonary vasculature. Thromb Haemost 81: 961-966.
14. Feigin DS, Bookstein JJ, Alazraki NP (1983). The effect of vasospasm on perfusion radionuclide imaging in experimental pulmonary embolism. Invest Radiol 18: 463-469.
15. Gustafsson LE, Leone AM, Persson MG, Wiklund NP, Moncada S (1991). Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun 181: 852-857.
16. Hamid Q, Springall DR, Riveros-Moreno V, Chanez P, Howarth P, Redington A et al. (1993). Induction of nitric oxide synthase in asthma. Lancet 342: 1510-1513.
17. Hlastala MP, Robertson HT, Ross BK (1979). Gas exchange abnormalities produced by venous gas emboli. Respir Physiol 36: 1-17.
18. Ide H, Nakano H, Ogasa T, Osanai S, Kikuchi K, Iwamoto J (1999). Regulation of pulmonary circulation by alveolar oxygen tension via airway nitric oxide. J Appl Physiol 87: 1629-1636.
19. McIntyre KM, Sasahara AA (1974). Hemodynamic and ventricular responses to pulmonary embolism. Prog Cardiovasc Dis 17: 175-190.
20. Meyer G, Roy PM, Sors H, Sanchez O (2003). Laboratory tests in the diagnosis of pulmonary embolism. Respiration 70: 125-132.
21. Murray IP, Mikhail MS, Banner MJ, Modell JH (1987). Pulmonary embolism: high-frequency jet ventilation offers advantages over conventional mechanical ventilation. Crit Care Med 15: 114-117.
22. Olin JW (2002). Pulmonary embolism. Rev Cardiovasc Med 3 (Suppl 2): S68-S75.
23. Paulus WJ, Bronzwaer JG (2004). Nitric oxide's role in the heart: control of beating or breathing? Am J Physiol Heart Circ Physiol 287: H8-H13.
24. Persson MG, Gustafsson LE, Wiklund NP, Moncada S, Hedqvist P (1990). Endogenous nitric oxide as a probable modulator of pulmonary circulation and hypoxic pressor response in vivo. Acta Physiol Scand 140: 449-457.
25. Persson MG, Midtvedt T, Leone AM, Gustafsson LE (1994). Ca(2+)-dependent and Ca(2+)-independent exhaled nitric oxide, presence in germ-free animals, and inhibition by arginine analogues. Eur J Pharmacol 264: 13-20.
26. Persson MG, Wiklund NP, Gustafsson LE (1993). Endogenous nitric oxide in single exhalations and the change during exercise. Am Rev Respir Dis 148: 1210-1214.
27. Priebe HJ (1988). Efficacy of vasodilator therapy in canine model of acute pulmonary hypertension. Am J Physiol 255: H1232-H1239.
28. Radomski MW, Palmer RM, Moncada S (1990). Characterization of the L-arginine:nitric oxide pathway in human platelets. Br J Pharmacol 101: 325-328.
29. Reeves WC, Demers LM, Wood MA, Skarlatos S, Copenhaver G, Whitesell L et al. (1983). The release of thromboxane A2 and prostacyclin following experimental acute pulmonary embolism. Prostaglandins Leukot Med 11: 1-10.
30. Ricciardolo FL, Sterk PJ, Gaston B, Folkerts G (2004). Nitric oxide in health and disease of the respiratory system. Physiol Rev 84: 731-765.
31. Rimeika D, Nyren S, Wiklund NP, Koskela Renström L, Törring A, Gustafsson LE et al. (2004). Regulation of regional lung perfusion by nitric oxide. Am J Respir Crit Care Med 170: 450-455.
32. Sander M, Welling KL, Ravn JB, Boberg B, Amtorp O (2003). Endogenous NO does not regulate baseline pulmonary pressure, but reduces acute pulmonary hypertension in dogs. Acta Physiol Scand 178: 269-277.
33. Schmeck J, Koch T, Patt B, Heller A, Neuhof H, van Ackern K (1998). The role of endothelin-1 as a mediator of the pressure response after air embolism in blood perfused lungs. Intensive Care Med 24: 605-611.
34. Sherman AJ, Davis III CA, Klocke FJ, Harris KR, Srinivasan G, Yaacoub AS et al. (1997). Blockade of nitric oxide synthesis reduces myocardial oxygen consumption in vivo. Circulation 95: 1328-1334.
35. Smith RE, Palmer RM, Moncada S (1991). Coronary vasodilatation induced by endotoxin in the rabbit isolated perfused heart is nitric oxide-dependent and inhibited by dexamethasone. Br J Pharmacol 104: 5-6.
36. Smulders YM (2000). Pathophysiology and treatment of haemodynamic instability in acute pulmonary embolism: the pivotal role of pulmonary vasoconstriction. Cardiovasc Res 48: 23-33.
37. Souza-Silva AR, Dias-Junior CA, Uzuelli JA, Moreno Jr H, Evora PR, Tanus-Santos JE (2005). Hemodynamic effects of combined sildenafil and L-arginine during acute pulmonary embolism-induced pulmonary hypertension. Eur J Pharmacol 524: 126-131.
38. Stamler JS, Loh E, Roddy MA, Currie KE, Creager MA (1994). Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation 89: 2035-2040.
39. Stratmann G, Gregory GA (2003). Neurogenic and humoral vasoconstriction in acute pulmonary thromboembolism. Anesth Analg 97: 341-354.
40. Strömberg S, Lönnqvist PA, Persson MG, Gustafsson LE (1997). Lung distension and carbon dioxide affect pulmonary nitric oxide formation in the anaesthetized rabbit. Acta Physiol Scand 159: 59-67.
41. Tajimi K, Tanaka H, Kasai T, Kobayashi K, Okuaki A (1989). Selective pulmonary vasodilatory effect of ZSY-27 in dogs with pulmonary hypertension due to pulmonary embolism. Crit Care Med 17: 163-165.
42. Tanaka H, Tajimi K, Matsumoto A, Kobayashi K (1990). Vasodilatory effects of milrinone on pulmonary vasculature in dogs with pulmonary hypertension due to pulmonary embolism: a comparison with those of dopamine and dobutamine. Clin Exp Pharmacol Physiol 17: 681-690.
43. Tanaka H, Tajimi K, Moritsune O, Kobayashi K, Okada K (1991). Effects of milrinone on pulmonary vasculature in normal dogs and in dogs with pulmonary hypertension. Crit Care Med 19: 68-74.
44. Utsunomiya T, Krausz MM, Shepro D, Hechtman HB (1981). Prostaglandin control of plasma and platelet 5-hydroxytryptamine in normal and embolized animals. Am J Physiol 241: H766-H771.
45. Vaughan DJ, Brogan TV, Kerr ME, Deem S, Luchtel DL, Swenson ER (2003). Contributions of nitric oxide synthase isozymes to exhaled nitric oxide and hypoxic pulmonary vasoconstriction in rabbit lungs. Am J Physiol Lung Cell Mol Physiol 284: L834-L843.
46. Via G, Braschi A (2004). Pathophysiology of severe pulmonary hypertension in the critically ill patient. Minerva Anestesiol 70: 233-237.
47. Wall MH, Patterson KW, Kavanagh BP, Pearl RG (1999). Inhibition of endogenous nitric oxide synthesis potentiates the effects of sodium nitroprusside but not of adenosine in experimental pulmonary hypertension. Pharmacology 58: 34-43.